POSCOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
POSITRON CORP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.70+0.15 (+9.68%)
Close on Oct 19, 2026
- Market cap
- $55.84M
- P/E (TTM)
- –
- Dividend yield
- –
POSITRON CORP revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2014 | FY2013 | FY2012 | FY2011 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| Radiopharmaceuticals | – | – | $17.00K | $0 | $12.00K | $0 | – | – |
| Medical equipment and service | – | – | $1.45M | $1.63M | $2.79M | $6.66M | – | – |
| Operating income | FY2025 | FY2024 | FY2014 | FY2013 | FY2012 | FY2011 | YoY |
|---|---|---|---|---|---|---|---|
| Radiopharmaceuticals | – | – | -$508.00K | -$862.00K | -$1.03M | $396.00K | – |
| Medical equipment and service | – | – | -$2.08M | -$2.49M | -$3.69M | $3.78M | – |
| Unallocated | – | – | $0 | $0 | -$6.00K | $221.00K | – |
By product or service
By region
From the segment and revenue-disaggregation notes of Positron's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.